136 related articles for article (PubMed ID: 27725127)
1. Vitamin D modulates different IL-17-secreting T cell subsets in multiple sclerosis patients.
da Costa DS; Hygino J; Ferreira TB; Kasahara TM; Barros PO; Monteiro C; Oliveira A; Tavares F; Vasconcelos CC; Alvarenga R; Bento CA
J Neuroimmunol; 2016 Oct; 299():8-18. PubMed ID: 27725127
[TBL] [Abstract][Full Text] [Related]
2. Different interleukin-17-secreting Toll-like receptor
Ferreira TB; Hygino J; Wing AC; Kasahara TM; Sacramento PM; Camargo S; Rueda F; Alves-Leon SV; Alvarenga R; Vasconcelos CC; Agrawal A; Gupta S; Bento CAM
Immunology; 2018 Jun; 154(2):239-252. PubMed ID: 29168181
[TBL] [Abstract][Full Text] [Related]
3. Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis.
Peelen E; Damoiseaux J; Muris AH; Knippenberg S; Smolders J; Hupperts R; Thewissen M
Mol Immunol; 2015 Feb; 63(2):521-9. PubMed ID: 25458313
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children.
Hamzaoui A; Berraïes A; Hamdi B; Kaabachi W; Ammar J; Hamzaoui K
Immunobiology; 2014 Nov; 219(11):873-9. PubMed ID: 25128460
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.
Wang HH; Dai YQ; Qiu W; Lu ZQ; Peng FH; Wang YG; Bao J; Li Y; Hu XQ
J Clin Neurosci; 2011 Oct; 18(10):1313-7. PubMed ID: 21795048
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients.
Naghavi Gargari B; Behmanesh M; Shirvani Farsani Z; Pahlevan Kakhki M; Azimi AR
Int Immunopharmacol; 2015 Sep; 28(1):414-9. PubMed ID: 26188623
[TBL] [Abstract][Full Text] [Related]
8. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
10. Major depression favors the expansion of Th17-like cells and decrease the proportion of CD39
do Sacramento PM; Sales M; Kasahara TM; Monteiro C; Oyamada H; Dias ASO; Lopes L; Castro CT; Rossi ÁD; Milioni LM; Agrawal A; Alvarenga R; Vasconcelos CC; Bento CAM
Cell Mol Life Sci; 2022 May; 79(6):298. PubMed ID: 35585332
[TBL] [Abstract][Full Text] [Related]
11. GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.
Peelen E; Muris AH; Damoiseaux J; Knippenberg S; Broens K; Smolders J; Cohen Tervaert JW; Hupperts R; Thewissen M
J Neuroimmunol; 2015 Mar; 280():36-42. PubMed ID: 25773153
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-mediated immune regulation in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
J Neurol Sci; 2011 Dec; 311(1-2):23-31. PubMed ID: 21723567
[TBL] [Abstract][Full Text] [Related]
13. Endogenous interleukin-6 amplifies interleukin-17 production and corticoid-resistance in peripheral T cells from patients with multiple sclerosis.
Ferreira TB; Hygino J; Barros PO; Teixeira B; Kasahara TM; Linhares UC; Lopes LM; Vasconcelos CC; Alvarenga R; Wing AC; Andrade RM; Andrade AF; Bento CA
Immunology; 2014 Dec; 143(4):560-8. PubMed ID: 24919524
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.
Lysandropoulos AP; Jaquiéry E; Jilek S; Pantaleo G; Schluep M; Du Pasquier RA
J Neuroimmunol; 2011 Apr; 233(1-2):240-4. PubMed ID: 21186064
[TBL] [Abstract][Full Text] [Related]
15. IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
Muls N; Nasr Z; Dang HA; Sindic C; van Pesch V
PLoS One; 2017; 12(3):e0173780. PubMed ID: 28301515
[TBL] [Abstract][Full Text] [Related]
16. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
17. Interactions of 1 alpha,25-dihydroxyvitamin D3 with IL-12 and IL-4 on cytokine expression of human T lymphocytes.
Thien R; Baier K; Pietschmann P; Peterlik M; Willheim M
J Allergy Clin Immunol; 2005 Sep; 116(3):683-9. PubMed ID: 16159643
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
19. CCR6
Restorick SM; Durant L; Kalra S; Hassan-Smith G; Rathbone E; Douglas MR; Curnow SJ
Brain Behav Immun; 2017 Aug; 64():71-79. PubMed ID: 28336414
[TBL] [Abstract][Full Text] [Related]
20. The activation of monocyte and T cell networks in patients with bipolar disorder.
Drexhage RC; Hoogenboezem TH; Versnel MA; Berghout A; Nolen WA; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1206-13. PubMed ID: 21443944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
